等待开盘 08-19 09:30:00 美东时间
+0.370
+2.47%
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
华盛资讯8月8日讯,Park Hotels & Resorts, Inc.公布2026财年Q2业绩,公司Q2营收6.80亿美元,同比增长1.2%,归母净利润0.47亿美元,扭亏为盈。
08-08 07:17
华盛资讯8月7日讯,Park Hotels & Resorts, Inc.公布2026财年Q2业绩,公司Q2营收6.44亿美元,同比增长6.1%,归母净利润0.47亿美元,扭亏为盈。
08-07 04:51
Park Hotels & Resorts (NYSE:PK) raises FY2026 FFO guidance from $1.74-$1.90 to $1.90-$2.00 vs $1.85 analyst estimate..
08-07 04:33
Park Hotels & Resorts (NYSE:PK) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.59 by 18.64 percent. This is a 9.37 percent increase over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $680.000 millio...
08-07 04:19
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37
Evercore ISI Group analyst Richard Hightower maintains Park Hotels & Resorts (NYSE:PK) with a In-Line and raises the price target from $15 to $16.
07-28 22:23
今日重点评级关注:HC Wainwright & Co.:维持Greenwich LifeSciences"买入"评级,目标价从50美元升至69美元;高盛:维持Taysha Gene Therapies"买入"评级,目标价从11美元升至13美元
07-22 11:35
今日重点评级关注:摩根大通:维持联合大陆航空"超配"评级,目标价从156美元升至203美元;摩根士丹利:维持联合大陆航空"超配"评级,目标价从185美元升至190美元
07-20 13:49
Morgan Stanley analyst Stephen Grambling maintains Park Hotels & Resorts (NYSE:PK) with a Equal-Weight and raises the price target from $10.5 to $11.
07-18 01:25